Open An Account RE-EKYC Account opening procedure Online Trading WEB MAIL
BSE Prices delayed by 5 minutes ! Prices as on   Apr 02, 2025 - 3:59PM   ABB India 5309 [ -1.46% ]ACC 1964.5 [ 0.67% ]Ambuja Cements 535.9 [ 1.23% ]Asian Paints Ltd. 2306.65 [ -0.38% ]Axis Bank Ltd. 1084.85 [ -0.05% ]Bajaj Auto 8062.6 [ 0.86% ]Bank of Baroda 231.5 [ 1.25% ]Bharti Airtel 1754.75 [ 1.79% ]Bharat Heavy Ele 212.5 [ 0.33% ]Bharat Petroleum 286.85 [ 0.72% ]Britannia Ind. 5048.3 [ 3.03% ]Cipla 1452.7 [ 0.56% ]Coal India 397.25 [ -0.21% ]Colgate Palm. 2366.75 [ 0.70% ]Dabur India 496.4 [ -0.24% ]DLF Ltd. 683.1 [ 3.19% ]Dr. Reddy's Labs 1149.75 [ -0.23% ]GAIL (India) 183.55 [ -1.48% ]Grasim Inds. 2614.5 [ -0.12% ]HCL Technologies 1531.85 [ 0.16% ]HDFC Bank 1797.4 [ 1.70% ]Hero MotoCorp 3782.2 [ 0.50% ]Hindustan Unilever L 2242 [ 0.37% ]Hindalco Indus. 661.25 [ -0.35% ]ICICI Bank 1330.75 [ 1.00% ]IDFC L 108 [ -1.77% ]Indian Hotels Co 829.7 [ 2.99% ]IndusInd Bank 702.4 [ 2.88% ]Infosys L 1549.85 [ 1.46% ]ITC Ltd. 408.95 [ 0.57% ]Jindal St & Pwr 908 [ 0.77% ]Kotak Mahindra Bank 2153 [ 0.36% ]L&T 3421.65 [ -0.41% ]Lupin Ltd. 2006.7 [ 2.57% ]Mahi. & Mahi 2637.7 [ 0.03% ]Maruti Suzuki India 11715.05 [ 2.09% ]MTNL 44.7 [ -1.74% ]Nestle India 2201.85 [ -1.36% ]NIIT Ltd. 123.3 [ -0.72% ]NMDC Ltd. 70.2 [ 0.65% ]NTPC 351.9 [ -0.07% ]ONGC 250.45 [ 0.93% ]Punj. NationlBak 97.34 [ 1.15% ]Power Grid Corpo 286.7 [ -0.88% ]Reliance Inds. 1251.1 [ -0.11% ]SBI 775.85 [ 0.56% ]Vedanta 457.3 [ 0.01% ]Shipping Corpn. 170 [ -0.09% ]Sun Pharma. 1714.25 [ 1.02% ]Tata Chemicals 848.45 [ 1.00% ]Tata Consumer Produc 1062.55 [ 7.12% ]Tata Motors 671.8 [ 0.06% ]Tata Steel 154.65 [ 1.01% ]Tata Power Co. 378.25 [ 0.93% ]Tata Consultancy 3545 [ -0.15% ]Tech Mahindra 1422.7 [ 2.04% ]UltraTech Cement 11276.35 [ -0.88% ]United Spirits 1432 [ 1.92% ]Wipro 263.65 [ 0.38% ]Zee Entertainment En 102.19 [ 0.64% ]
BSE MCX

MARKETS

News Details

( As on 18/03/2025 15:51)

Cipla inks licensing agreement with Formosa Pharmaceuticals

Cipla announced on Tuesday that it has entered into an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the commercialization of clobetasol propionate ophthalmic suspension.

Under the agreement, the Mumbai-based pharmaceutical company gains exclusive marketing rights for the USFDA-approved, patent-protected drug (APP13007) across 11 countries, including India, South Africa, Nepal, Sri Lanka, Bangladesh, Malaysia, Myanmar, Kenya, Nigeria, Argentina, and Colombia. The ophthalmic suspension is indicated for treating post-operative inflammation and pain following ocular surgery.